Prognostic Prediction Models for Ulcerative Colitis: Systematic Review and Meta-Analysis.
Zhijun Bu1, Yuan Sun1, Zeyang Shi1
1School of Traditional Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, 11 Beisanhuan East Road, Chaoyang District, Beijing, 100029, China, 86 17800176627.
Prognostic models for ulcerative colitis (UC) show promise but need improvement. Most models have high bias and limited generalizability, requiring better validation for clinical use.
Area of Science:
- Gastroenterology and Hepatology
- Clinical Epidemiology
- Biostatistics
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with variable patient outcomes.
- Prognostic models are crucial for personalized medicine in UC but require thorough evaluation.
- Current quality and clinical utility of UC prognostic models are not well-assessed.
Purpose of the Study:
- To systematically review and critically evaluate prognostic prediction models for UC.
- Assess the development, performance, and clinical applicability of existing UC prognostic models.
Main Methods:
- Comprehensive literature search across major databases up to November 2024.
- Data extraction on study characteristics, model development, and validation metrics.
- Risk of bias and applicability assessment using the Prediction Model Risk of Bias Assessment Tool.
- Meta-analysis to evaluate pooled model performance (AUC).
Main Results:
- 30 studies with 7452 UC patients were included; most were retrospective.
- Models predicted treatment response (e.g., to TNF-alpha inhibitors), surgery risk, or relapse.
- Pooled AUC was 0.84, but 97% of studies had high risk of bias.
- Limited external validation (47%) and generalizability concerns (60%) were noted.
Conclusions:
- UC prognostic models demonstrate potential but are limited by high bias and insufficient validation.
- Future research must focus on multicenter validation and refined model development.
- Enhancing model applicability is key for broader clinical implementation in UC management.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
